3rd Circ. Nixes Class' Appeal Of Fen-Phen Atty Fees

Law360, New York (June 7, 2010, 7:07 PM EDT) -- A federal appeals court has rejected an appeal by 36 class members over the $434 million in attorneys' fees awarded in litigation against Wyeth over the diet drug fen-phen, concluding their objection came too late.

The U.S. Court of Appeals for the Third Circuit on Monday upheld a lower court decision to deny the plaintiffs' bid for reconsideration of an order granting the $434 million in fees, which was split among 90 law firms.

The court said the plaintiffs had failed to offer an explanation for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.